ICON-1

· Iconic Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ICON-1, covering 2020-09-14 to 2021-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) [Phase 2]

See pricing